Polymorphisms of β-adrenoceptor and Natriuretic Peptide Receptor Genes Influence the Susceptibility to and the Severity of Idiopathic Dilated Cardiomyopathy in a Chinese Cohort

Journal of Cardiac Failure

Volumn 16, Issue 1, 2010, Pages 36-44

  Wang, Lingjie ^a   Lu, Lin ^a   Zhang, Fengru ^a   Chen, Qiujing ^a   Shen, Weifeng ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

adrenoceptor; Idiopathic dilated cardiomyopathy; natriuretic peptide receptor; polymorphism

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; APOLIPOPROTEIN A; APOLIPOPROTEIN B; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CREATININE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOSE; GLYCINE; HIGH DENSITY LIPOPROTEIN; INOTROPIC AGENT; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; NATRIURETIC PEPTIDE RECEPTOR 1; NATRIURETIC PEPTIDE RECEPTOR 2; NITROGEN; RENIN INHIBITOR; SERINE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UREA; URIC ACID; ATRIAL NATRIURETIC FACTOR RECEPTOR; BETA ADRENERGIC RECEPTOR; NATRIURETIC PEPTIDE RECEPTOR B;

ADULT; AGED; ARTICLE; CHINESE; COHORT ANALYSIS; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DYSPNEA; FEMALE; FOLLOW UP; FOOT EDEMA; GENE FREQUENCY; GENE INTERACTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; HEART FAILURE; HETEROZYGOTE; HOMOZYGOTE; HOSPITALIZATION; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEPTOR GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL; UREA BLOOD LEVEL; URIC ACID BLOOD LEVEL; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOMYOPATHY, DILATED; COMPARATIVE STUDY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOMYOPATHY, DILATED; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ATRIAL NATRIURETIC FACTOR; SEVERITY OF ILLNESS INDEX;

EID: 72749109804     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2009.08.003     Document Type: Article

References (34)

1. Komajda M., Charron P., and Tesson F. Genetic aspects of heart failure. Eur J Heart Fail 1 (1999) 121-126
2. Schonberger J., and Seidman C.E. Many roads lead to a broken heart: the genetics of dilated cardiomyopathy. Am J Hum Genet 69 (2001) 249-260
3. Poller W., Kuhl U., Tschoepe C., Pauschinger M., Fechner H., and Schultheiss H.P. Genome-environment interactions in the molecular pathogenesis of dilated cardiomyopathy. J Mol Med 83 (2005) 579-586
4. Eisenhofer G., Friberg P., Rundqvist B., Quyyumi A.A., Lambert G., Kaye D.M., et al. Cardiac sympathetic nerve function in congestive heart failure. Circulation 93 (1996) 1667-1676
5. Podlowski S., Wenzel K., Luther H.P., Muller J., Bramlage P., Baumann G., et al. Beta1-adrenoceptor gene variations: a role in idiopathic dilated cardiomyopathy?. J Mol Med 78 (2000) 87-93
6. Green S.A., Turki J., Innis M., and Liggett S.B. Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 33 (1994) 9414-9419
7. Green S.A., Cole G., Jacinto M., Innis M., and Liggett S.B. A polymorphism of the human beta 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor. J Biol Chem 268 (1993) 23116-23121
8. Moniotte S., Kobzik L., Feron O., Trochu J.N., Gauthier C., and Balligand J.L. Upregulation of beta (3)-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium. Circulation 103 (2001) 1649-1655
9. Rathz D.A., Brown K.M., Kramer L.A., and Liggett S.B. Amino acid 49 polymorphisms of the human beta1-adrenergic receptor affect agonist-promoted trafficking. J Cardiovasc Pharmacol 39 (2002) 155-160
10. Mason D.A., Moore J.D., Green S.A., and Liggett S.B. A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor. J Biol Chem 274 (1999) 12670-12674
11. Wei C.M., Kim C.H., Khraibi A.A., Miller V.M., and Burnett Jr. J.C. Atrial natriuretic peptide and C-type natriuretic peptide in spontaneously hypertensive rats and their vasorelaxing actions in vitro. Hypertension 23 (1994) 903-907
12. Rubattu S., Stanzione R., Di Angelantonio E., Zanda B., Evangelista A., Tarasi D., et al. Atrial natriuretic peptide gene polymorphisms and risk of ischemic stroke in humans. Stroke 35 (2004) 814-818
13. Rahmutula D., Nakayama T., Soma M., Kosuge K., Aoi N., Izumi Y., et al. Structure and polymorphisms of the human natriuretic peptide receptor C gene. Endocrine 17 (2002) 85-90
14. Rahmutula D., Nakayama T., Soma M., Sato M., Izumi Y., Kanmatsuse K., et al. Systematic screening of type B human natriuretic peptide receptor gene polymorphisms and association with essential hypertension. J Hum Hypertens 15 (2001) 471-474
15. Weber M., Burian M., Dragutinovic I., Moellmann H., Nef H., Elsaesser A., et al. Genetic polymorphism of the type A human natriuretic peptide receptor (NPR-A) gene contributes to the interindividual variability in the BNP system. Eur J Heart Fail 10 (2008) 482-489
16. Knowles J.W., Erickson L.M., Guy V.K., Sigel C.S., Wilder J.C., and Maeda N. Common variations in noncoding regions of the human natriuretic peptide receptor A gene have quantitative effects. Hum Genet 112 (2003) 62-70
17. Richardson P., McKenna W., Bristow M., Maisch B., Mautner B., O'Connell J., et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 93 (1996) 841-842
18. DiBianco R.A. large-scale trial of captopril for mild to moderate heart failure in the primary care setting. Clin Cardiol 14 (1991) 676-682
19. Torp-Pedersen C.T., Moller M., Bloch-Thomsen P.E., Kober L., Sandoe E., Egstrup K., et al. [Dofetilide to patients with heart failure and left ventricular dysfunction]. Ugeskr Laeger 162 (2000) 5948-5953
20. Maggioni A.P., Zuanetti G., Franzosi M.G., Rovelli F., Santoro E., Staszewsky L., et al. Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI-2 results. Circulation 87 (1993) 312-322
21. Kaye D.M., Smirk B., Williams C., Jennings G., Esler M., and Holst D. Beta-adrenoceptor genotype influences the response to carvedilol in patients with congestive heart failure. Pharmacogenetics 13 (2003) 379-382
22. Schaid D.J., Rowland C.M., Tines D.E., Jacobson R.M., and Poland G.A. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70 (2002) 425-434
23. Moore J.H., Gilbert J.C., Tsai C.T., Chiang F.T., Holden T., Barney N., et al. A flexible computational framework for detecting, characterizing, and interpreting statistical patterns of epistasis in genetic studies of human disease susceptibility. J Theor Biol 241 (2006) 252-261
24. Tsai C.T., Lai L.P., Lin J.L., Chiang F.T., Hwang J.J., Ritchie M.D., et al. Renin-angiotensin system gene polymorphisms and atrial fibrillation. Circulation 109 (2004) 1640-1646
25. Rahmutula D., Nakayama T., Soma M., Takahashi Y., Uwabo J., Sato M., et al. A C2077T polymorphism of the type B human natriuretic peptide receptor gene is not associated with myocardial infarction. Med Sci Monit 6 (2000) 1056-1060
26. Turki J., Lorenz J.N., Green S.A., Donnelly E.T., Jacinto M., and Liggett S.B. Myocardial signaling defects and impaired cardiac function of a human beta 2-adrenergic receptor polymorphism expressed in transgenic mice. Proc Natl Acad Sci U S A 93 (1996) 10483-10488
27. Maqbool A., Hall A.S., Ball S.G., and Balmforth A.J. Common polymorphisms of beta1-adrenoceptor: identification and rapid screening assay. Lancet 353 (1999) 897
28. Levin M.C., Marullo S., Muntaner O., Andersson B., and Magnusson Y. The myocardium-protective Gly-49 variant of the beta 1-adrenergic receptor exhibits constitutive activity and increased desensitization and down-regulation. J Biol Chem 277 (2002) 30429-30435
29. Pierpont G.L., Francis G.S., DeMaster E.G., Levine T.B., Bolman R.M., and Cohn J.N. Elevated left ventricular myocardial dopamine in preterminal idiopathic dilated cardiomyopathy. Am J Cardiol 52 (1983) 1033-1035
30. Sole M.J., and Liew C.C. Catecholamines, calcium and cardiomyopathy. Am J Cardiol 62 (1988) 20G-24G
31. Lohmann F.W. [Sympathetic activity in patients with heart failure due to idiopathic dilated cardiomyopathy: modification by beta receptor blockers-a therapeutic approach?]. Herz 15 (1990) 202-206
32. Forleo C., Sorrentino S., Guida P., Romito R., De Tommasi E., Iacoviello M., et al. Beta1- and beta2-adrenergic receptor polymorphisms affect susceptibility to idiopathic dilated cardiomyopathy. J Cardiovasc Med (Hagerstown) 8 (2007) 589-595
33. Forleo C., Resta N., Sorrentino S., Guida P., Manghisi A., De Luca V., et al. Association of beta-adrenergic receptor polymorphisms and progression to heart failure in patients with idiopathic dilated cardiomyopathy. Am J Med 117 (2004) 451-458
34. Ginsburg G.S., Shah S.H., and McCarthy J.J. Taking cardiovascular genetic association studies to the next level. J Am Coll Cardiol 50 (2007) 930-932